Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin

Acta Haematologica

Volumn 124, Issue 2, 2010, Pages 98-102

  Ojeda Uribe, Mario ^a   Herbrecht, Raoul ^b   Kiefer, Marie Hélène ^a   Schultz, Philippe ^b   Chain, Jorge ^a   Chenard, Marie Pierre ^b   Servant, Jean Marie ^c   Debry, Christian ^b  

^a Hôpitaux Universitaires de Strasbourg   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Acute myeloid leukaemia; Amphotericin B lipid formulation; Caspofungin; Mandibular prosthesis; Mucormycosis

Indexed keywords

AMPHOTERICIN B; BIOMATERIAL; CASPOFUNGIN; ANTIFUNGAL AGENT; ECHINOCANDIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DRUG FORMULATION; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; MANDIBLE; MUCORMYCOSIS; PLASTIC SURGERY; PRIORITY JOURNAL; CHIN; COMPLICATION; DRUG COMBINATION; MICROBIOLOGY; MIDDLE AGED; MOUTH; NECROSIS; PATHOLOGY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHIN; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MANDIBLE; MIDDLE AGED; MOUTH; MUCORMYCOSIS; NECROSIS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 77955119147     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315675     Document Type: Article

References (23)

1. Spellberg B, Walsh T, Kontoyiannis DP, Edwards J, Ibrahim A: Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48:1743-1751.
2. Gonzalez CE, Rinaldi MG, Sugar AM: Mu-cormycosis. Infect Dis Clin N Am 2002; 16: 895-914.
3. Roden MM, Zaouitis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyi-annis DP, Walsh TJ: Epidemiology and outcome of mucormycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
4. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, Corvatta L, D'Antonio D, Girmenia C, Martino P, Del Favero A: Mucormycosis in hematologic patients. Haematologica 2004; 89: 207-214.
5. Barron M, Lay M, Madinger NE: Surgery and treatment with high-dose liposomal ampho-tericin B for eradication of craniofacial mu-cormycosis in a patient with Hodgkin's disease who had undergone allogeneic he-matopoietic stem cell transplantation. J Clin Microbiol 2005; 43: 2012-2014.
6. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ: Am-photericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383-1396.
7. Witz F, Harousseau JL, Sadoun A, Cahn JY, Le Prise PY, Tournilihac O, Desablens B, Guyotat D, Vilque JP, Berthou C, Solary E, Ojeda M, François S, Delain M, Dorvaux V, Raby P, Berthaud P, Lioure B: A randomized study of fludarabine in part of induction and post-remission treatment for de novo acute myeloid leukemia (AML) in elderly patients. Blood 2000; 96(suppl 1):504a.
8. Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R, Spellberg B: Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008; 47:364-371.
9. Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie E: Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericine B (Am-Bisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 2001; 45:3487-3496.
10. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S: In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. An-timicrob Agents Chemother 2007; 51 : 2587-2590.
11. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R: Posacon-azole as salvage therapy for mucormycosis. Antimicrob Agents Chemother 2006; 50: 126-133.
12. Spellberg B, Fu Y, Edwards J Jr, Ibrahim S: Combination therapy with ABLC and caspo-fungin acetate of disseminated mucormyco-sis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005; 49: 830-832.
13. Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JJ, Douglas CM: Caspofungin inhibits Rhizopus oryzae 1,3-D-glucan synthase, lowers quantitative PCR-measured brain burden, and improves survival at a low but not at a high dose during murine disseminated mucormycosis. Anti-microb Agents Chemother 2005; 49:721-727.
14. Larsen K, von Buchwald C, Ellefsen B, Francis D: Unexpected expansive paranasal sinus mucormycosis. OR L 2003; 65: 57-60.
15. Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF: Successful treatment of rhinocerebral mucormyco-sis with a combination of caspofungin and liposomal amphotericin B. Haematologica 2005; 90(suppl 12):ECR39.
16. Guembe M, Guinea J, Pelaez T, Torres-Narbona M, Bouza E: Interaction between posaconazole and caspofungin against clinical zygomycetes: a synergistic effect. Anti-microb Agents Chemother 2007; 51 : 35 47-3548.
17. Jones AC, Bentsen TY, Freedman PD: Mu-cormycosis of the oral cavity. Oral Surg Oral Med Ora l Pathol 1993; 75: 455-460.
18. Paydas S, Yavuz S, Disel U, Yildirim M, Be-sen A, Sahin B, Gumurdulu D, Yuce E: Mu-cormycosis of the tongue in a patient with acute lymphoblastic leukemia: a possible relation with use of a tongue depressor. Am J Med 2003; 114:618-620.
19. Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE: Pulmonary mucormy-cosis: results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044-1050.
20. Schultz P, Vautier D, Chluba J, Marcellin L, Debry C: Survival analysis of rats implanted with porous titanium tracheal prosthesis. Ann Thorac Surg 2002; 73: 1747-1751.
21. Boyd JB, Mulholland RS, Davidson J, Gullane PJ, Rotstein LE, Brown DH, Freeman JE, Irish JC: The free flap and plate in oromandibular reconstruction: long-term review and indication. Plast Reconstr Surg 1995; 95:1018-1028.
22. Nicholson RE, Schuller DE, Forrest LA, Mountain RE, Tahir A, Young D: Factors involved in long-and short-term mandibular plate exposure. Arch Otolaryngol Head Neck Surg 1997; 123:217-222.
23. Arden RL, Rachel JD, Marks SC, Dang K: Volume-length impact of lateral jaw resections on complication rates. Arch Otolaryn-gol Head Neck Surg 1999; 125:68-72.